GC
MDRX

Guggenheim Capital’s Veradigm Inc. Common Stock MDRX Stock Holding History

Guggenheim Capital’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,375
Closed -$424K – 1963
2023
Q4 		$424K Sell
40,375
-3,869
-9% -$47.4K ﹤0.01% 1521
2023
Q3 		$581K Buy
44,244
+2,716
+7% +$35.6K 0.01% 1345
2023
Q2 		$523K Buy
41,528
+26,823
+182% +$326K ﹤0.01% 1452
2023
Q1 		$192K Sell
14,705
-1,311
-8% -$21.2K ﹤0.01% 1809
2022
Q4 		$283K Buy
+16,016
New +$268K ﹤0.01% 1689
2021
Q3 		– Sell
-13,922
Closed -$258K – 2253
2021
Q2 		$258K Sell
13,922
-1,392
-9% -$23.4K ﹤0.01% 2074
2021
Q1 		$230K Sell
15,314
-12,321
-45% -$197K ﹤0.01% 2041
2020
Q4 		$399K Buy
+27,635
New +$334K ﹤0.01% 1730
2018
Q4 		– Sell
-57,987
Closed -$826K – 2406
2018
Q3 		$826K Sell
57,987
-5,126
-8% -$69.7K 0.01% 1719
2018
Q2 		$759K Sell
63,113
-6,493
-9% -$80K 0.01% 1746
2018
Q1 		$860K Buy
69,606
+6,902
+11% +$98.1K ﹤0.01% 2152
2017
Q4 		$914K Sell
62,704
-20,959
-25% -$291K ﹤0.01% 2123
2017
Q3 		$1.19M Buy
83,663
+7,318
+10% +$94.7K ﹤0.01% 1999
2017
Q2 		$974K Buy
76,345
+16,163
+27% +$196K ﹤0.01% 2094
2017
Q1 		$764K Sell
60,182
-89,526
-60% -$1.06M ﹤0.01% 2241
2016
Q4 		$1.53M Buy
149,708
+6,301
+4% +$71.9K ﹤0.01% 1875
2016
Q3 		$1.89M Buy
143,407
+33,971
+31% +$454K 0.01% 1656
2016
Q2 		$1.39M Buy
109,436
+32,695
+43% +$434K ﹤0.01% 1813
2016
Q1 		$1.01M Sell
76,741
-5,673
-7% -$74.5K ﹤0.01% 2045
2015
Q4 		$1.27M Buy
82,414
+6,111
+8% +$87.6K ﹤0.01% 1961
2015
Q3 		$946K Sell
76,303
-33,978
-31% -$468K ﹤0.01% 2129
2015
Q2 		$1.51M Buy
110,281
+3,271
+3% +$44.2K ﹤0.01% 1969
2015
Q1 		$1.28M Sell
107,010
-1,581,007
-94% -$19.3M ﹤0.01% 2105
2014
Q4 		$21.6M Sell
1,688,017
-138,937
-8% -$1.77M 0.05% 618
2014
Q3 		$24.5M Buy
1,826,954
+1,663,989
+1,021% +$25.2M 0.06% 562
2014
Q2 		$2.62M Buy
162,965
+106,746
+190% +$1.66M 0.01% 1595
2014
Q1 		$1.01M Buy
56,219
+3,343
+6% +$57.8K ﹤0.01% 2259
2013
Q4 		$817K Buy
52,876
+37,899
+253% +$558K ﹤0.01% 2333
2013
Q3 		$223K Sell
14,977
-71,315
-83% -$1.08M ﹤0.01% 2698
2013
Q2 		$1.12M Buy
+86,292
New +$1.16M ﹤0.01% 1966

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital's MDRX Position: Q1 2024 in Review

Guggenheim Capital sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 40,375 shares — an estimated $424K sold.

Guggenheim Capital first reported a position in MDRX in Q2 2013 and held it in 30 quarters. The position peaked at $24.5M in Q3 2014. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Guggenheim Capital reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Guggenheim Capital sold 40,375 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $424K.
  • Guggenheim Capital first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 30 quarters.
  • Guggenheim Capital's Veradigm Inc. Common Stock position peaked at $24.5M in Q3 2014.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Guggenheim Capital's 13F filing for Q1 2024, filed 14 May 2024.